EPIC Program Annual Report 2009-2010 Appendix: Table VII

Table VII
Ten Most Frequently Purchased Types of Drugs
by Therapeutic Classification^*

Therapeutic Class**	Number of Claims	Percent of Claims	EPIC Payments	Percent of Payments	Number of Participants
Total***	4,118,831	42.56%	$99,762,767	29.91%
BETA-ADRENERGIC BLOCKING AGENT	711,168	7.35%	$6,860,753	2.06%	142,017
HMG-COA REDUCTASE INHIBITORS	699,898	7.23%	$26,179,385	7.85%	153,381
ANGIOTENSIN-CONVERTING ENZYME	418,081	4.32%	$1,998,966	0.60%	89,725
PROTON-PUMP INHIBITORS	404,434	4.18%	$25,683,079	7.69%	90,931
ANTIDEPRESSANTS	352,621	3.64%	$8,459,008	2.54%	65,546
ANGIOTENSIN II RECEPTOR ANTAGONIST	348,404	3.60%	$18,563,452	5.57%	70,475
DIHYDROPYRIDINES	340,490	3.52%	$5,036,048	1.51%	72,376
THYROID AGENTS	298,592	3.09%	$1,715,667	0.51%	58,592
OPIATE AGONISTS	293,123	3.03%	$4,757,248	1.43%	78,717
LOOP DIURETICS	252,020	2.60%	$509,161	0.15%	61,784

^* Table VII provides the percent of adjudicated claims for the program year (October 1, 2009 through September 30, 2010) as they fall into particular categories of Therapeutic Class.

^** American Hospital Formulary Service® (AHFS) Pharmacologic-Therapeutic Classification.

^*** This report contains the top ten drug classes, additional drug classes will comprise the remainder of claims up to 100.00%.